Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102619
Revised: January 7, 2025
Accepted: February 25, 2025
Published online: April 15, 2025
Processing time: 153 Days and 7.8 Hours
Centromere protein A (CENPA) exhibits an increased expression level in primary human rectal cancer tissues, but its role has not been investigated.
To clarify the specific role and mechanism of CENPA in rectal cancer progression.
CENPA protein expression in rectal cancer tissues and cell lines were detected. CENPA was overexpressed and knocked down in SW837 and SW480 cells, and proliferation, invasion, apoptosis and epithelial-mesenchymal transition (EMT) marker protein levels were examined. O6-methylguanine DNA methyltransferase (MGMT) promoter methylation was assessed with methylation-specific poly
CENPA was upregulated in rectal cancer tissues and cell lines. CENPA overexpression promoted proliferation, invasion and EMT, and inhibited apoptosis in rectal cancer cells. Whereas CENPA knockdown showed the opposite results. Moreover, CENPA inhibited MGMT expression by promoting DNA methyltransferase 1-mediated MGMT promoter methylation. MGMT knockdown abolished the CENPA knockdown-mediated inhibition of rectal cancer cell progression. MGMT increased PTPN4 protein stability by inhibiting PTPN4 ubiquitination degradation via competing with ubiquitin-conjugating enzyme E2O for interacting with PTPN4. PTPN4 knockdown abolished the inhibitory effects of MGMT overexpression on rectal cancer cell progression. Moreover, CENPA knockdown inhibited xenograft tumor growth in vivo.
CENPA knockdown inhibited rectal cancer cell growth and attenuated xenograft tumor growth through regulating the MGMT/PTPN4 axis.
Core Tip: This study suggested that centromere protein A (CENPA) was upregulated in rectal cancer tissues and cell lines. CENPA overexpression promoted proliferation, invasion and epithelial-mesenchymal transition, and inhibited apoptosis in rectal cancer cells. Whereas CENPA knockdown showed the opposite results. Additionally, CENPA knockdown inhibited xenograft tumor growth in vivo. Mechanistically, CENPA inhibited O6-methylguanine DNA methyltransferase (MGMT) expression by promoting DNA methyltransferase 1-mediated MGMT promoter methylation. MGMT interacted with protein tyrosine phosphatase nonreceptor type 4 (PTPN4) and increased PTPN4 protein stability. CENPA knockdown inhibited rectal cancer progression through regulating the MGMT/PTPN4 axis.
